Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Fluoxetine induces elevation of desipramine level and exacerbation of geriatric nonpsychotic depression.

× No keyword cloud information.

10 in total

1. Inhibitors of imipramine metabolism by human liver microsomes.

Authors: E Skjelbo; K Brøsen
Journal: Br J Clin Pharmacol Date: 1992-09 Impact factor: 4.335

2. Fluoxetine and norfluoxetine are potent inhibitors of P450IID6--the source of the sparteine/debrisoquine oxidation polymorphism.

Authors: K Brøsen; E Skjelbo
Journal: Br J Clin Pharmacol Date: 1991-07 Impact factor: 4.335

3. Pharmacokinetics of desipramine HCl when administered with cinacalcet HCl.

Authors: Robert Z Harris; Margaret Salfi; Ed Posvar; David Hoelscher; Desmond Padhi
Journal: Eur J Clin Pharmacol Date: 2006-05-08 Impact factor: 2.953

Review 4. The Black Book of Psychotropic Dosing and Monitoring.

Authors: Alan F Schatzberg; DeBattista Charles
Journal: Psychopharmacol Bull Date: 2018-01-15

Review 5. Clinically significant drug interactions with antidepressants in the elderly.

Authors: Edoardo Spina; Maria Gabriella Scordo
Journal: Drugs Aging Date: 2002 Impact factor: 3.923

Review 6. Selective serotonin reuptake inhibitors and CNS drug interactions. A critical review of the evidence.

Authors: B A Sproule; C A Naranjo; K E Brenmer; P C Hassan
Journal: Clin Pharmacokinet Date: 1997-12 Impact factor: 6.447

Review 7. Clinical pharmacokinetics of imipramine and desipramine.

Authors: F R Sallee; B G Pollock
Journal: Clin Pharmacokinet Date: 1990-05 Impact factor: 6.447

Review 8. Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in older patients with depressive illness.

Authors: M G Harris; P Benfield
Journal: Drugs Aging Date: 1995-01 Impact factor: 3.923

9. Inhibition by paroxetine of desipramine metabolism in extensive but not in poor metabolizers of sparteine.

Authors: K Brøsen; J G Hansen; K K Nielsen; S H Sindrup; L F Gram
Journal: Eur J Clin Pharmacol Date: 1993 Impact factor: 2.953

10. Tricyclic antidepressant plasma levels after augmentation with citalopram: a case study.

Authors: D Baettig; G Bondolfi; S Montaldi; M Amey; P Baumann
Journal: Eur J Clin Pharmacol Date: 1993 Impact factor: 2.953

10 in total